A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer (JUNIPER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02152631
Recruitment Status : Active, not recruiting
First Posted : June 2, 2014
Last Update Posted : October 19, 2017
Information provided by (Responsible Party):
Eli Lilly and Company